279 related articles for article (PubMed ID: 16190744)
1. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
Armer RE; Ashton MR; Boyd EA; Brennan CJ; Brookfield FA; Gazi L; Gyles SL; Hay PA; Hunter MG; Middlemiss D; Whittaker M; Xue L; Pettipher R
J Med Chem; 2005 Oct; 48(20):6174-7. PubMed ID: 16190744
[TBL] [Abstract][Full Text] [Related]
2. Diazine indole acetic acids as potent, selective, and orally bioavailable antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases.
Kaila N; Huang A; Moretto A; Follows B; Janz K; Lowe M; Thomason J; Mansour TS; Hubeau C; Page K; Morgan P; Fish S; Xu X; Williams C; Saiah E
J Med Chem; 2012 Jun; 55(11):5088-109. PubMed ID: 22651823
[TBL] [Abstract][Full Text] [Related]
3. Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2.
Hata AN; Lybrand TP; Marnett LJ; Breyer RM
Mol Pharmacol; 2005 Mar; 67(3):640-7. PubMed ID: 15563582
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
5. On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2.
Mathiesen JM; Christopoulos A; Ulven T; Royer JF; Campillo M; Heinemann A; Pardo L; Kostenis E
Mol Pharmacol; 2006 Apr; 69(4):1441-53. PubMed ID: 16418339
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a new class of potent, selective, and orally active prostaglandin D2 receptor antagonists.
Torisu K; Kobayashi K; Iwahashi M; Nakai Y; Onoda T; Nagase T; Sugimoto I; Okada Y; Matsumoto R; Nanbu F; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem; 2004 Oct; 12(20):5361-78. PubMed ID: 15388164
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.
Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H
J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
10. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
11. Development of a prostaglandin D2 receptor antagonist: discovery of a new chemical lead.
Torisu K; Kobayashi K; Iwahashi M; Egashira H; Nakai Y; Okada Y; Nanbu F; Ohuchida S; Nakai H; Toda M
Eur J Med Chem; 2005 May; 40(5):505-19. PubMed ID: 15893024
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of MK-7246, a potent and selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells) antagonist.
Gervais FG; Sawyer N; Stocco R; Hamel M; Krawczyk C; Sillaots S; Denis D; Wong E; Wang Z; Gallant M; Abraham WM; Slipetz D; Crackower MA; O'Neill GP
Mol Pharmacol; 2011 Jan; 79(1):69-76. PubMed ID: 20943773
[TBL] [Abstract][Full Text] [Related]
13. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats.
Shichijo M; Sugimoto H; Nagao K; Inbe H; Encinas JA; Takeshita K; Bacon KB; Gantner F
J Pharmacol Exp Ther; 2003 Nov; 307(2):518-25. PubMed ID: 12975488
[TBL] [Abstract][Full Text] [Related]
14. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.
Monneret G; Cossette C; Gravel S; Rokach J; Powell WS
J Pharmacol Exp Ther; 2003 Jan; 304(1):349-55. PubMed ID: 12490611
[TBL] [Abstract][Full Text] [Related]
15. Development of prostaglandin D2 receptor antagonist: discovery of highly potent antagonists.
Torisu K; Kobayashi K; Iwahashi M; Nakai Y; Onoda T; Nagase T; Sugimoto I; Okada Y; Matsumoto R; Nanbu F; Ohuchida S; Nakai H; Masaaki Toda
Bioorg Med Chem; 2004 Sep; 12(17):4685-700. PubMed ID: 15358295
[TBL] [Abstract][Full Text] [Related]
16. 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists.
Sandham DA; Adcock C; Bala K; Barker L; Brown Z; Dubois G; Budd D; Cox B; Fairhurst RA; Furegati M; Leblanc C; Manini J; Profit R; Reilly J; Stringer R; Schmidt A; Turner KL; Watson SJ; Willis J; Williams G; Wilson C
Bioorg Med Chem Lett; 2009 Aug; 19(16):4794-8. PubMed ID: 19592244
[TBL] [Abstract][Full Text] [Related]
17. 2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists.
Sandham DA; Aldcroft C; Baettig U; Barker L; Beer D; Bhalay G; Brown Z; Dubois G; Budd D; Bidlake L; Campbell E; Cox B; Everatt B; Harrison D; Leblanc CJ; Manini J; Profit R; Stringer R; Thompson KS; Turner KL; Tweed MF; Walker C; Watson SJ; Whitebread S; Willis J; Williams G; Wilson C
Bioorg Med Chem Lett; 2007 Aug; 17(15):4347-50. PubMed ID: 17531480
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
Crosignani S; Prêtre A; Jorand-Lebrun C; Fraboulet G; Seenisamy J; Augustine JK; Missotten M; Humbert Y; Cleva C; Abla N; Daff H; Schott O; Schneider M; Burgat-Charvillon F; Rivron D; Hamernig I; Arrighi JF; Gaudet M; Zimmerli SC; Juillard P; Johnson Z
J Med Chem; 2011 Oct; 54(20):7299-317. PubMed ID: 21916510
[TBL] [Abstract][Full Text] [Related]
19. Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis.
Pettipher R; Whittaker M
J Med Chem; 2012 Apr; 55(7):2915-31. PubMed ID: 22224640
[No Abstract] [Full Text] [Related]
20. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
